HK1138774A1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- HK1138774A1 HK1138774A1 HK10105492.0A HK10105492A HK1138774A1 HK 1138774 A1 HK1138774 A1 HK 1138774A1 HK 10105492 A HK10105492 A HK 10105492A HK 1138774 A1 HK1138774 A1 HK 1138774A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007016789 | 2007-01-26 | ||
| PCT/JP2008/000040 WO2008090732A1 (ja) | 2007-01-26 | 2008-01-17 | 医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1138774A1 true HK1138774A1 (en) | 2010-09-03 |
Family
ID=39644307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10105492.0A HK1138774A1 (en) | 2007-01-26 | 2010-06-03 | Pharmaceutical composition |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8541459B2 (xx) |
| EP (1) | EP2116241B1 (xx) |
| JP (1) | JP5297815B2 (xx) |
| KR (1) | KR101408680B1 (xx) |
| CN (1) | CN101621997B (xx) |
| DK (1) | DK2116241T3 (xx) |
| HK (1) | HK1138774A1 (xx) |
| TW (1) | TWI500421B (xx) |
| WO (1) | WO2008090732A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5297815B2 (ja) | 2007-01-26 | 2013-09-25 | 株式会社ポーラファルマ | 医薬組成物 |
| CN101541324B (zh) | 2007-06-14 | 2011-06-15 | 株式会社宝丽制药 | 医药组合物 |
| CN101642452B (zh) * | 2008-08-06 | 2014-05-28 | 株式会社宝丽制药 | 脑肿瘤用放射线敏化剂 |
| JP2015091766A (ja) * | 2013-09-30 | 2015-05-14 | 株式会社ポーラファルマ | 癌治療支援システム |
| US20190298835A1 (en) * | 2018-03-29 | 2019-10-03 | U.S. Army Research Laboratory | Administration of tailored feedstock to increase antibiotic susceptibility |
| US11684597B2 (en) | 2019-01-28 | 2023-06-27 | The United States Of America As Represented By The Secretary Of The Army | Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility |
| CN110105371B (zh) * | 2019-05-06 | 2020-10-27 | 深圳万乐药业有限公司 | 一种多拉达唑原料药中的杂质及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4462992A (en) * | 1982-02-08 | 1984-07-31 | Research Corporation | Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof |
| US4797397A (en) * | 1987-07-31 | 1989-01-10 | Warner-Lambert Company | 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells |
| US5036060A (en) * | 1988-07-25 | 1991-07-30 | Fujisawa Usa, Inc. | Cyclophosphamide |
| JP2701482B2 (ja) | 1989-10-23 | 1998-01-21 | オムロン株式会社 | ソレノイド装置 |
| KR927003539A (ko) | 1990-01-26 | 1992-12-18 | 스즈끼 쯔네시 | 2-니트로 이미다졸 유도체, 그의 제조방법 및 이를 유효성분으로 하는 방사선 증감제 |
| JP3223258B2 (ja) | 1992-06-24 | 2001-10-29 | 株式会社キーエンス | 稼働状態監視装置 |
| ES2199221T3 (es) | 1992-12-18 | 2004-02-16 | Pola Chemical Industries, Inc. | Derivado de 2-nitro-imidazol opticamente activo, procedimiento para prepararlo, y compuesto intermedio para prepararlo. |
| JP3136306B2 (ja) | 1993-10-26 | 2001-02-19 | 丸石製薬株式会社 | 静脈注射用ニトロプルシドナトリウム注射剤 |
| EP0795134B1 (en) | 1994-11-28 | 2002-08-28 | Abbott Laboratories | Stabilized aqueous steroid immunoassay standards |
| US5834315A (en) * | 1994-12-23 | 1998-11-10 | Coulter Corporation | Cyanide-free reagent and method for hemoglobin determination and leukocyte differentitation |
| US5700825A (en) * | 1995-03-31 | 1997-12-23 | Florida State University | Radiosensitizing diamines and their pharmaceutical preparations |
| JPH0977667A (ja) | 1995-09-12 | 1997-03-25 | Pola Chem Ind Inc | 核酸塩基水酸化物消去促進剤 |
| EP0764675B1 (en) * | 1995-09-19 | 1998-05-13 | Mitsubishi Gas Chemical Company, Inc. | Biodegrable water-soluble polymer |
| US5961955A (en) * | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| WO1999009997A1 (en) * | 1997-08-26 | 1999-03-04 | Board Of Regents, The University Of Texas System | Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
| GB9925127D0 (en) | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
| CA2413538A1 (en) * | 2000-07-06 | 2002-01-17 | Bristol-Myers Squibb Pharma Company | Stable radiopharmaceutical compositions and methods for preparation thereof |
| AU2003213184A1 (en) * | 2002-02-22 | 2003-09-09 | Pharmacia And Upjohn Company | Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
| CN104383542B (zh) | 2003-04-08 | 2017-09-26 | 普罗热尼奇制药公司 | 包含甲基纳曲酮的药物配方 |
| JP4288337B2 (ja) | 2003-07-08 | 2009-07-01 | 株式会社ポーラファルマ | 低酸素性細胞増感剤の増感効果の鑑別法及び低酸素条件下アポトーシス・シグナル保持剤 |
| GB0501192D0 (en) | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
| JP2007106736A (ja) * | 2005-09-14 | 2007-04-26 | Pola Chem Ind Inc | 注射用の医薬組成物 |
| JP2007191417A (ja) * | 2006-01-19 | 2007-08-02 | Pola Chem Ind Inc | 医薬用の組成物 |
| JP5297815B2 (ja) | 2007-01-26 | 2013-09-25 | 株式会社ポーラファルマ | 医薬組成物 |
| CN101541324B (zh) | 2007-06-14 | 2011-06-15 | 株式会社宝丽制药 | 医药组合物 |
-
2008
- 2008-01-17 JP JP2008554998A patent/JP5297815B2/ja active Active
- 2008-01-17 DK DK08702781.9T patent/DK2116241T3/en active
- 2008-01-17 EP EP08702781.9A patent/EP2116241B1/en active Active
- 2008-01-17 WO PCT/JP2008/000040 patent/WO2008090732A1/ja active Application Filing
- 2008-01-17 CN CN2008800029708A patent/CN101621997B/zh active Active
- 2008-01-17 US US12/523,067 patent/US8541459B2/en active Active
- 2008-01-17 KR KR1020097013776A patent/KR101408680B1/ko active IP Right Grant
- 2008-03-07 TW TW097108192A patent/TWI500421B/zh active
-
2010
- 2010-06-03 HK HK10105492.0A patent/HK1138774A1/xx unknown
-
2012
- 2012-01-31 US US13/362,527 patent/US8450356B2/en active Active
- 2012-01-31 US US13/362,545 patent/US8420687B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090102782A (ko) | 2009-09-30 |
| US8420687B2 (en) | 2013-04-16 |
| US20120130148A1 (en) | 2012-05-24 |
| CN101621997A (zh) | 2010-01-06 |
| EP2116241B1 (en) | 2016-04-27 |
| US20120129905A1 (en) | 2012-05-24 |
| US8450356B2 (en) | 2013-05-28 |
| KR101408680B1 (ko) | 2014-06-17 |
| EP2116241A1 (en) | 2009-11-11 |
| JP5297815B2 (ja) | 2013-09-25 |
| TWI500421B (zh) | 2015-09-21 |
| EP2116241A4 (en) | 2010-07-21 |
| WO2008090732A1 (ja) | 2008-07-31 |
| CN101621997B (zh) | 2013-05-08 |
| DK2116241T3 (en) | 2016-06-06 |
| JPWO2008090732A1 (ja) | 2010-05-20 |
| US8541459B2 (en) | 2013-09-24 |
| TW200938190A (en) | 2009-09-16 |
| US20100076042A1 (en) | 2010-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1800007I1 (hu) | Gyógyászati készítmény | |
| IL247741A0 (en) | pharmaceutical preparations | |
| EP2133095A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2133094A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2191826A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HK1136968A1 (en) | Novel pharmaceutical composition | |
| IL200125A0 (en) | Pharmaceutical composition | |
| EP2222313A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2116242A4 (en) | NEW PHARMACEUTICAL COMPOSITION | |
| EP2224805A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2224915A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2146695A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| HK1138774A1 (en) | Pharmaceutical composition | |
| EP2224808A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0709811D0 (en) | Pharmaceutical compositions | |
| EP2156832A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0707127D0 (en) | Pharmaceutical compositions | |
| EP2224806A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL205975A0 (en) | Pharmaceutical composition | |
| GB0712454D0 (en) | Pharmaceutical compositions | |
| IL205931A0 (en) | Pharmaceutical composition | |
| GB2454923B (en) | Pharmaceutical compositions | |
| IL201394A0 (en) | Niacin - based pharmaceutical compositions | |
| GB0717036D0 (en) | Pharmaceutical composition | |
| GB0712558D0 (en) | Pharmaceutical composition |